Nov 10. 2021
(¥ million)
| Brand name | Active Ingredient | Indications | Launch Date | Sales 2019 | Sales 2020 | Sales 2021 | |
|---|---|---|---|---|---|---|---|
| Apr.-Sep. |
Annual (estimated) |
||||||
| Vidaza | azacitidine |
myelodysplastic syndrome/ acute myeloid leukemia |
Mar-2011/ Mar-2021 |
15,652 | 15,350 | 9,059 | 17,200 |
| Uptravi | selexipag |
pulmonary arterial hypertension/ chronic thromboembolic pulmonary hypertension |
Nov-2016/ Aug-2021 |
6,182 | 6,804 | 3,851 | 8,600 |
| Tramal, Onetram | tramadol hydrochloride | cancer pain, chronic pain | Sep-2010 | 7,153 | 6,906 | 3,444 | 6,100 |
| Viltepso | viltolarsen |
Duchenne muscular dystrophy |
Japan May-2020 U.S. Aug-2020 |
- | 2,387 | 3,142 | 8,800 |
| Gazyva | obinutuzumab | CD20-positive follicular lymphoma | Aug-2018 | 4,527 | 5,312 | 2,616 | 6,100 |
| Adcirca | tadalafil | pulmonary arterial hypertension | Dec-2009 | 5,405 | 5,474 | 2,599 | 4,800 |
| Zalutia | tadalafil | urinary disorder caused by benign prostatic hyperplasia | Apr-2014 | 13,328 | 6,743 | 2,191 | 3,200 |
| Cialis | tadalafil | erectile dysfunction | Jul-2009 | 4,472 | 2,677 | 1,212 | 2,500 |
| Defitelio | defibrotide sodium | sinusoidal obstruction syndrome | Sep-2019 | 1,071 | 1,970 | 956 | 2,100 |
| Erizas | dexamethasone cipecilate | allergic rhinitis | Dec-2009 | 2,387 | 2,444 | 649 | 2,500 |
| Profit in co-promotion | 5,963 | 8,442 | 4,464 | 9,000 | |||
| Revenues from the licensing of industrial property rights | 15,860 | 24,338 | 20,964 | 32,000 | |||
| Pharmaceuticals | 101,643 | 106,478 | 63,430 | 119,300 | |||
| Functional Food | 14,994 | 15,406 | 8,138 | 15,700 | |||
| Net Sales | 116,637 | 121,885 | 71,568 | 135,000 | |||
| Brand name | Active Ingredient | Indications | Launch Date | Sales 2019 | Sales 2020 | Apr.-Sep. | |
|---|---|---|---|---|---|---|---|
| Sales 2021 |
Annual (estimated) |
||||||
| Vidaza | azacitidine |
myelodysplastic syndrome/ acute myeloid leukemia |
Mar-2011/ Mar-2021 |
15,652 | 15,350 | 9,059 | 17,200 |
| Uptravi | selexipag |
pulmonary arterial hypertension/ chronic thromboembolic pulmonary hypertension |
Nov-2016/ Aug-2021 |
6,182 | 6,804 | 3,851 | 8,600 |
| Tramal, Onetram | tramadol hydrochloride | cancer pain, chronic pain | Sep-2010 | 7,153 | 6,906 | 3,444 | 6,100 |
| Viltepso | viltolarsen |
Duchenne muscular dystrophy |
Japan May-2020 U.S. Aug-2020 |
- | 2,387 | 3,142 | 8,800 |
| Gazyva | obinutuzumab | CD20-positive follicular lymphoma | Aug-2018 | 4,527 | 5,312 | 2,616 | 6,100 |
| Adcirca | tadalafil | pulmonary arterial hypertension | Dec-2009 | 5,405 | 5,474 | 2,599 | 4,800 |
| Zalutia | tadalafil | urinary disorder caused by benign prostatic hyperplasia | Apr-2014 | 13,328 | 6,743 | 2,191 | 3,200 |
| Cialis | tadalafil | erectile dysfunction | Jul-2009 | 4,472 | 2,677 | 1,212 | 2,500 |
| Defitelio | defibrotide sodium | sinusoidal obstruction syndrome | Sep-2019 | 1,071 | 1,970 | 956 | 2,100 |
| Erizas | dexamethasone cipecilate | allergic rhinitis | Dec-2009 | 2,387 | 2,444 | 649 | 2,500 |
| Profit in co-promotion | 5,963 | 8,442 | 4,464 | 9,000 | |||
| Revenues from the licensing of industrial property rights | 15,860 | 24,338 | 20,964 | 32,000 | |||
| Pharmaceuticals | 101,643 | 106,478 | 63,430 | 119,300 | |||
| Functional Food | 14,994 | 15,406 | 8,138 | 15,700 | |||
| Net Sales | 116,637 | 121,885 | 71,568 | 135,000 | |||